Astaxanthin reduces ischemic brain injury in adult rats

被引:118
作者
Shen, Hui [1 ]
Kuo, Chi-Chung [1 ]
Chou, Jenny [1 ]
Delvolve, Alice [1 ]
Jackson, Shelley N. [1 ]
Post, Jeremy [1 ]
Woods, Amina S. [1 ]
Hoffer, Barry J. [1 ]
Wang, Yun [1 ]
Harvey, Brandon K. [1 ]
机构
[1] NIDA, NIH, Intramural Res Program, Baltimore, MD 21224 USA
关键词
antioxidant; stroke; neuroprotection; apoptosis; glutamate; FOCAL CEREBRAL-ISCHEMIA; ALGA HAEMATOCOCCUS-PLUVIALIS; PENAEUS-MONODON FABRICIUS; NIVALIS BAUER WILLE; OXIDATIVE STRESS; RAINBOW-TROUT; DIETARY SUPPLEMENTATION; SYNTHETIC ASTAXANTHIN; ANTIOXIDANT ACTIVITY; ONCORHYNCHUS-MYKISS;
D O I
10.1096/fj.08-123281
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Astaxanthin (ATX) is a dietary carotenoid of crustaceans and fish that contributes to their coloration. Dietary ATX is important for development and survival of salmonids and crustaceans and has been shown to reduce cardiac ischemic injury in rodents. The purpose of this study was to examine whether ATX can protect against ischemic injury in the mammalian brain. Adult rats were injected intracerebroventricularly with ATX or vehicle prior to a 60-min middle cerebral artery occlusion (MCAo). ATX was present in the infarction area at 70-75 min after onset of MCAo. Treatment with ATX, compared to vehicle, increased locomotor activity in stroke rats and reduced cerebral infarction at 2 d after MCAo. To evaluate the protective mechanisms of ATX against stroke, brain tissues were assayed for free radical damage, apoptosis, and excitoxicity. ATX antagonized ischemia-mediated loss of aconitase activity and reduced glutamate release, lipid peroxidation, translocation of cytochrome c, and TUNEL labeling in the ischemic cortex. ATX did not alter physiological parameters, such as body temperature, brain temperature, cerebral blood flow, blood gases, blood pressure, and pH. Collectively, our data suggest that ATX can reduce ischemia-related injury in brain tissue through the inhibition of oxidative stress, reduction of glutamate release, and antiapoptosis. ATX may be clinically useful for patients vulnerable or prone to ischemic events.-Shen, H., Kuo, C.-C., Chou, J., Delvolve, A., Jackson, S. N., Post, J., Woods, A. S., Hoffer, B. J., Wang, Y., Harvey, B. K. Astaxanthin reduces ischemic brain injury in adult rats. FASEB J. 23, 1958-1968 (2009)
引用
收藏
页码:1958 / 1968
页数:11
相关论文
共 65 条
[31]   MALDI-ion mobility-TOFMS imaging of lipids in rat brain tissue [J].
Jackson, Shelley N. ;
Ugarov, Michael ;
Egan, Thomas ;
Post, Jeremy D. ;
Langlais, Denis ;
Schultz, J. Albert ;
Woods, Amina S. .
JOURNAL OF MASS SPECTROMETRY, 2007, 42 (08) :1093-1098
[32]   Neuroprotective properties of the natural vitamin E α-tocotrienol [J].
Khanna, S ;
Roy, S ;
Slivka, A ;
Craft, TKS ;
Chaki, S ;
Rink, C ;
Notestine, MA ;
DeVries, AC ;
Parinandi, NL ;
Sen, CK .
STROKE, 2005, 36 (10) :E144-E152
[33]   In vivo antioxidant role of astaxanthin under oxidative stress in the green alga Haematococcus pluvialis [J].
Kobayashi, M .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2000, 54 (04) :550-555
[34]  
Lee SJ, 2003, MOL CELLS, V16, P97
[35]   Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke [J].
Leinonen, JS ;
Ahonen, JP ;
Lönnrot, K ;
Jehkonen, M ;
Dastidar, P ;
Molnár, G ;
Alho, H .
STROKE, 2000, 31 (01) :33-39
[36]   Ketamine antagonizes nitric oxide release from cerebral cortex after middle cerebral artery ligation in rats [J].
Lin, SZ ;
Chiou, AL ;
Wang, Y .
STROKE, 1996, 27 (04) :747-752
[37]   Cis astaxanthin and especially 9-cis astaxanthin exhibits a higher antioxidant activity in vitro compared to the all-trans isomer [J].
Liu, Xuebo ;
Osawa, Toshihiko .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 357 (01) :187-193
[38]  
Lockwood SF, 2005, CARDIOVASC DRUG REV, V23, P199
[39]   Modulatory effects of an algal extract containing astaxanthin on UVA-irradiated cells in culture [J].
Lyons, NM ;
O'Brien, NM .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2002, 30 (01) :73-84
[40]   Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant [J].
Mackensen, GB ;
Patel, M ;
Sheng, HX ;
Calvi, CL ;
Batinic-Haberle, I ;
Day, BJ ;
Liang, LP ;
Fridovich, I ;
Crapo, JD ;
Pearlstein, RD ;
Warner, DS .
JOURNAL OF NEUROSCIENCE, 2001, 21 (13) :4582-4592